SAN FRANCISCO, Sept. 30, 2019 /PRNewswire/ -- Hagens Berman notifies investors in Myriad Genetics, Inc. (NASDAQ: MYGN) of the pending securities class action and urges MYGN investors who have suffered losses in excess of $50,000 to contact the firm. CLASS PERIOD: Sept. 2, 2016 – Aug. 13,...
from PR Newswire: https://ift.tt/2mp7t0M
No comments:
Post a Comment